Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001193125-23-257772
Filing Date
2023-10-17
Accepted
2023-10-17 17:28:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFC14A d545928ddefc14a.htm DEFC14A 243824
2 GRAPHIC g545928g63p02.jpg GRAPHIC 33742
  Complete submission text file 0001193125-23-257772.txt   292233
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filed by) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Subject) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFC14A | Act: 34 | File No.: 001-41827 | Film No.: 231330439
SIC: 2834 Pharmaceutical Preparations